Patents by Inventor Garron Dodd

Garron Dodd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260191933
    Abstract: The present invention relates to pharmaceutical combinations for treating or preventing insulin resistance and associated disorders, in particular the use combinations comprising a 4-epimerase inhibitor and a GLP-1 receptor agonist for treating or preventing insulin resistance and associating disorders such as obesity and type-2 diabetes, supressing appetite and/or promoting weight loss.
    Type: Application
    Filed: November 28, 2023
    Publication date: July 9, 2026
    Inventors: Garron DODD, Cait Anwen BEDDOWS, Feiyue SHI, Callen Charles LUCAS-GOLDSMITH
  • Publication number: 20260174677
    Abstract: The present invention relates to methods of treating or preventing insulin resistance and associated disorders, in particular the use of 4-epimerase inhibitors for treating or preventing insulin resistance and associating disorders, such as obesity and type-2 diabetes.
    Type: Application
    Filed: October 27, 2023
    Publication date: June 25, 2026
    Inventors: Garron DODD, Cait BEDDOWS, Feiyue SHI
  • Patent number: 11273166
    Abstract: The present invention generally relates to methods and compositions for the treatment of overweight or obese individuals. In particular, the invention relates to reducing adiposity of an overweight or obese individual. The present invention provides a method for reducing adiposity or treating obesity in an individual, the method comprising inhibiting TCPTP and/or PTP1B in the hypothalamus of the individual, thereby reducing adiposity or treating obesity in the individual.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: March 15, 2022
    Assignee: Monash University
    Inventors: Garron Dodd, Tony Tiganis
  • Publication number: 20200197415
    Abstract: The present invention generally relates to methods and compositions for the treatment of overweight or obese individuals. In particular, the invention relates to reducing adiposity of an overweight or obese individual. The present invention provides a method for reducing adiposity or treating obesity in an individual, the method comprising inhibiting TCPTP and/or PTP1B in the hypothalamus of the individual, thereby reducing adiposity or treating obesity in the individual.
    Type: Application
    Filed: June 13, 2018
    Publication date: June 25, 2020
    Inventors: Garron Dodd, Tony Tiganis